P
189.99
27.28 (16.77%)
| 前收盘价格 | 162.71 |
| 收盘价格 | 178.94 |
| 成交量 | 4,422,289 |
| 平均成交量 (3个月) | 735,656 |
| 市值 | 4,021,315,584 |
| 价格/销量 (P/S) | 144.69 |
| 股市价格/股市净资产 (P/B) | 2.87 |
| 52周波幅 | |
| 利润日期 | 6 Nov 2025 |
| 营业利益率 (TTM) | -2,868.84% |
| 稀释每股收益 (EPS TTM) | -10.66 |
| 季度收入增长率 (YOY) | 1,349.10% |
| 总债务/股东权益 (D/E MRQ) | 0.24% |
| 流动比率 (MRQ) | 8.44 |
| 营业现金流 (OCF TTM) | -163.91 M |
| 杠杆自由现金流 (LFCF TTM) | -90.04 M |
| 资产报酬率 (ROA TTM) | -39.95% |
| 股东权益报酬率 (ROE TTM) | -63.56% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Praxis Precision Medicines, Inc | 看涨 | 看涨 |
AIStockmoo 评分
0.8
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -5.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.75 |
|
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.16% |
| 机构持股比例 | 122.02% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Perceptive Advisors Llc | 30 Jun 2025 | 752,921 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 360.00 (Truist Securities, 89.48%) | 购买 |
| 中 | 280.00 (47.38%) | |
| 低 | 73.00 (Wedbush, -61.58%) | 卖出 |
| 平均值 | 250.89 (32.05%) | |
| 总计 | 8 购买, 1 卖出 | |
| 平均价格@调整类型 | 164.81 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wedbush | 20 Oct 2025 | 73.00 (-61.58%) | 卖出 | 189.99 |
| Chardan Capital | 17 Oct 2025 | 330.00 (73.69%) | 购买 | 189.99 |
| 29 Jul 2025 | 80.00 (-57.89%) | 购买 | 55.96 | |
| Deutsche Bank | 17 Oct 2025 | 280.00 (47.38%) | 购买 | 189.99 |
| Guggenheim | 17 Oct 2025 | 350.00 (84.22%) | 购买 | 189.99 |
| Truist Securities | 17 Oct 2025 | 360.00 (89.48%) | 购买 | 189.99 |
| HC Wainwright & Co. | 16 Oct 2025 | 232.00 (22.11%) | 购买 | 162.71 |
| 05 Aug 2025 | 115.00 (-39.47%) | 购买 | 47.79 | |
| Jefferies | 16 Oct 2025 | 300.00 (57.90%) | 购买 | 162.71 |
| Needham | 16 Oct 2025 | 250.00 (31.59%) | 购买 | 162.71 |
| Jones Trading | 18 Sep 2025 | 83.00 (-56.31%) | 购买 | 45.23 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合